References
- APA. Diagnostic and statistical manual of mental disorders DSM-5. 5th ed. Washington, DC: American Psychiatric Association; 2013.
- Erskine HE, Ferrari AJ, Nelson P, Polanczyk GV, Flaxman AD, Vos T, et al. Epidemiological modelling of attention-deficit/hyperactivity disorder and conduct disorder for the global burden of disease study 2010. J Child Psychol Psyc 2013;54(12):1263–74.
- Polanczyk G, de Lima MS, Horta BL, Biederman J, Rohde LA. The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry 2007;164(6):942–8.
- Kessler RC, Adler L, Barkley R, Biederman J, Conners CK, Demler O, et al. The prevalence and correlates of adult ADHD in the United States: results from the national comorbidity survey replication. Am J Psychiatry 2006;163(4):716–23.
- Barkley RA, Fischer M, Smallish L, Fletcher K. Young adult outcome of hyperactive children: adaptive functioning in major life activities. J Am Acad Child Adolesc Psychiatry 2006;45(2):192–202.
- Nigg JT. Attention-deficit/hyperactivity disorder and adverse health outcomes. Clin Psychol Rev 2013;33:215–28.
- Nigg JT, Johnstone JM, Musser ED, Long HG, Willoughby M, Shannon J. Attention-deficit/hyperactivity disorder (ADHD) and being overweight/obesity: new data and meta-analysis. Clin Psychol Rev 2016;43:67–79.
- Faraone SV, Asherson P, Banaschewski T, Biederman J, Buitelaar JK, Ramos-Quiroga JA, et al. Attention-deficit/hyperactivity disorder. Nat Rev Dis Primers 2015;49:15020.
- Jacobson MF. Diet, ADHD & behavior: a quarter-century review. Washington, DC: Center for Science in the Public Interest; 1999.
- Feingold BF. Hyperkinesis and learning disabilities linked to artificial food flavors and colors. Am J Nurs 1975;75(5):797–803.
- Kavale KA, Forness SR. Hyperactivity and diet treatment: a meta-analysis of the Feingold hypothesis. J Learn Disabil 1983;16(6):324–30.
- Mattes JA. The Feingold diet: a current reappraisal. J Learn Disabil 1983;16(6):319–23.
- Bateman B, Warner JO, Hutchinson E, Dean T, Rowlandson P, Gant C, et al. The effects of a double blind, placebo controlled, artificial food colourings and benzoate preservative challenge on hyperactivity in a general population sample of preschool children. Arch Dis Child 2004;89(6):506–11.
- Schab DW, Trinh NHT. Do artificial food colors promote hyperactivity in children with hyperactive syndromes? A meta-analysis of double-blind placebo-controlled trials. J Dev Behav Pediatr 2004;25(6):423–34.
- Stevenson J, Sonuga-Barke E, McCann D, Grimshaw K, Parker KM, Rose-Zerilli MJ, et al. The role of histamine degradation gene polymorphisms in moderating the effects of food additives on children’s ADHD symptoms. Am J Psychiatry 2010;167(9):1108–15.
- Nigg JT, Lewis K, Edinger T, Falk M. Meta-analysis of attention-deficit/hyperactivity disorder or attention-deficit/hyperactivity disorder symptoms, restriction diet, and synthetic food color additives. J Am Acad Child Adolesc Psychiatry 2012;51(1):86–97.e8.
- Jacka FN, Kremer PJ, Berk M, de Silva-Sanigorski AM, Moodie M, Leslie ER, et al. A prospective study of diet quality and mental health in adolescents. PLoS One 2011;6(9):e24805.
- Jacka FN, O’Neil A, Opie R, Itsiopoulos C, Cotton S, Mohebbi M, et al. A randomised controlled trial of dietary improvement for adults with major depression (the “SMILES” trial). BMC Med 2017;15(1):181.
- Howard AL, Robinson M, Smith GJ, Ambrosini GL, Piek JP, Oddy WH. ADHD is associated with a “western” dietary pattern in adolescents. J Atten Disord 2011;15(5):403–11.
- Ríos-Hernández A, Alda JA, Farran-Codina A, Ferreira-García E, Izquierdo-Pulido M. The Mediterranean diet and ADHD in children and adolescents. Pediatrics 2017;139(2):e20162027.
- Jacka FN, Ystrom E, Brantsaeter AL, Karevold E, Roth C, Haugen M, et al. Maternal and early postnatal nutrition and mental health of offspring by age 5 years: a prospective cohort study. J Am Acad Child Adolesc Psychiatry 2013;52(10):1038–47.
- Monk C, Georgieff MK, Osterholm EA. Research review: maternal prenatal distress and poor nutrition – mutually influencing risk factors affecting infant neurocognitive development. J Child Psychol Psyc 2013;54(2):115–30.
- Galler JR, Bryce CP, Zichlin ML, Fitzmaurice G, Eaglesfield GD, Waber DP. Infant malnutrition is associated with persisting attention deficits in middle adulthood. J Nutr 2012;142(4):788–94.
- Golub MS, Takeuchi PT, Keen CL, Hendrickx AG, Gershwin ME. Activity and attention in zinc-deprived adolescent monkeys. Am J Clin Nutr 1996;64(6):908–15.
- Aggett P, Harries J. Current status of zinc in health and disease states. Arch Dis Child 1979;54(12):909–17.
- Veran J, Kumar J, Pinheiro PS, Athané A, Mayer ML, Perrais D, et al. Zinc potentiates GluK3 glutamate receptor function by stabilizing the ligand binding domain dimer interface. Neuron 2012;76(3):565–78.
- Biederman J. Attention-deficit/hyperactivity disorder: a selective overview. Biol Psychia 2005;57(11):1215–20.
- Yager JY, Hartfield DS. Neurologic manifestations of iron deficiency in childhood. Pediatr Neurol 2002;27(2):85–92.
- Beard JL, Chen Q, Connor J, Jones BC. Altered monamine metabolism in caudate-putamen of iron-deficient rats. Pharmacol Biochem Behav 1994;48(3):621–4.
- Konofal E, Lecendreux M, Arnulf I, Mouren MC. Iron deficiency in children with attention-deficit/hyperactivity disorder. Arch Pediat Adol Med 2004;158(12):1113–5.
- Millichap JG, Yee MM, Davidson SI. Serum ferritin in children with attention-deficit hyperactivity disorder. Pediatr Neurol 2006;34(3):200–3.
- Bilici M, Yıldırım F, Kandil S, Bekaroğlu M, Yıldırmış S, Değer O, et al. Double-blind, placebo-controlled study of zinc sulfate in the treatment of attention deficit hyperactivity disorder. Prog Neuropsychopharmacol Biol Psychiatry 2004;28(1):181–90.
- Sever Y, Ashkenazi A, Tyano S, Weizman A. Iron treatment in children with attention deficit hyperactivity disorder. Neuropsychobiology 1997;35(4):178–80.
- Konofal E, Lecendreux M, Deron J, Marchand M, Cortese S, Zaïm M, et al. Effects of iron supplementation on attention deficit hyperactivity disorder in children. Pediatr Neurol 2008;38(1):20–6.
- Rucklidge J, Taylor M, Whitehead K. Effect of micronutrients on behavior and mood in adults with ADHD: evidence from an 8-week open label trial with natural extension. J Atten Disord 2011;15(1):79–91.
- Rucklidge JJ, Frampton CM, Gorman B, Boggis A. Vitamin-mineral treatment of attention-deficit hyperactivity disorder in adults: double-blind randomised placebo-controlled trial. Br J Psychiatry 2014;204(4):306–15.
- Gordon HA, Rucklidge JJ, Blampied NM, Johnstone JM. Clinically significant symptom reduction in children with attention-deficit/hyperactivity disorder treated with micronutrients: an open-label reversal design study. J Child Adol Psychop 2015;25(10):783–98.
- Shabbir F, Patel A, Mattison C, Bose S, Krishnamohan R, Sweeney E, et al. Effect of diet on serotonergic neurotransmission in depression. Neurochem Int 2013;62(3):324–9.
- Werner ER, Blau N, Thöny B. Tetrahydrobiopterin: biochemistry and pathophysiology. Biochem J 2011;438(3):397–414.
- Nikolaev MV, Magazanik LG, Tikhonov DB. Influence of external magnesium ions on the NMDA receptor channel block by different types of organic cations. Neuropharmacology 2012;62(5–6):2078–85.
- Russell VA. Dopamine hypofunction possibly results from a defect in glutamate-stimulated release of dopamine in the nucleus accumbens shell of a rat model for attention deficit hyperactivity disorder – the spontaneously hypertensive rat. Neurosci Biobehav R 2003;27(7):671–82.
- Banerjee E, Nandagopal K. Does serotonin deficit mediate susceptibility to ADHD? Neurochem Int 2015;82:52–68.
- Bari A, Robbins TW. Noradrenergic versus dopaminergic modulation of impulsivity, attention and monitoring behaviour in rats performing the stop-signal task: possible relevance to ADHD. Psychopharmacology 2013;230(1):89–111.
- Wurtman RJ, editor. Food consumption, neurotransmitter synthesis, and human behaviour. Nutritional adequacy, nutrient availability and needs: Nestlé nutrition research symposium; 1982 Sep 14–15; Vevey. Birkhäuser; 2013.
- Shnitko TA, Taylor SC, Stringfield SJ, Zandy SL, Cofresi RU, Doherty JM, et al. Acute phenylalanine/tyrosine depletion of phasic dopamine in the rat brain. Psychopharmacology 2016;233(11):2045–54.
- Russo S, Kema IP, Bosker F, Haavik J, Korf J. Tryptophan as an evolutionarily conserved signal to brain serotonin: molecular evidence and psychiatric implications. World J Biol Psychia 2009;10(4):258–68.
- Holton K, Nigg J. The association of lifestyle factors and ADHD in children. J Atten Disord 2016.
- Cools R, Roberts AC, Robbins TW. Serotoninergic regulation of emotional and behavioural control processes. Trends Cogn Sci 2008;12(1):31–40.
- Mette C, Zimmermann M, Grabemann M, Abdel-Hamid M, Uekermann J, Biskup CS, et al. The impact of acute tryptophan depletion on attentional performance in adult patients with ADHD. Acta Psychiat Scand 2013;128(2):124–32.
- Moult PR. Neuronal glutamate and GABAA receptor function in health and disease. Biochem Soc T 2009;37(Pt 6):1317–22.
- Errico F, Napolitano F, Nistico R, Centonze D, Usiello A. D-aspartate: an atypical amino acid with neuromodulatory activity in mammals. Rev Neuroscience 2009;20(5–6):429–40.
- Hernandes MS, Troncone LR. Glycine as a neurotransmitter in the forebrain: a short review. J Neural Transm 2009;116(12):1551–60.
- Grayson DS, Kroenke CD, Neuringer M, Fair DA. Dietary omega-3 fatty acids modulate large-scale systems organization in the rhesus macaque brain. J Neurosci 2014;34(6):2065–74.
- Janssen CI, Kiliaan AJ. Long-chain polyunsaturated fatty acids (LCPUFA) from genesis to senescence: the influence of LCPUFA on neural development, aging, and neurodegeneration. Prog Lipid Res 2014;53:1–17.
- Hawkey E, Nigg JT. Omega-3 fatty acid and ADHD: blood level analysis and meta-analytic extension of supplementation trials. Clin Psychol Rev 2014;34(6):496–505.
- Bergwerff CE, Luman M, Blom HJ, Oosterlaan J. No tryptophan, tyrosine and phenylalanine abnormalities in children with attention-deficit/hyperactivity disorder. PloS One 2016;11(3):e0151100.
- Musser ED, Galloway-Long HS, Frick PJ, Nigg JT. Emotion regulation and heterogeneity in attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 2013;52(2):163–171.e2.
- Musser ED, Karalunas SL, Dieckmann N, Peris TS, Nigg JT. Attention-deficit/hyperactivity disorder developmental trajectories related to parental expressed emotion. J Abnorm Psychol 2016;125(2):182–95.
- Moshfegh AJ, Rhodes DG, Baer DJ, Murayi T, Clemens JC, Rumpler WV, et al. The US department of agriculture automated multiple-pass method reduces bias in the collection of energy intakes. Am J Clin Nutr 2008;88(2):324–32.
- Guenther PM, Casavale KO, Reedy J, Kirkpatrick SI, Hiza HA, Kuczynski KJ, et al. Update of the healthy eating index: HEI-2010. J Acad Nutr Diet 2013;113(4):569–80.
- Institute of Medicine. Dietary reference intakes (DRIs): recommended dietary allowances and adequate intakes, vitamins, elements. United States Department of Agriculture; 2011. Available from: https://fnic.nal.usda.gov/sites/fnic.nal.usda.gov/files/uploads/RDA_AI_vitamins_elements.pdf
- Rogers JL, Howard KI, Vessey JT. Using significance tests to evaluate equivalence between two experimental groups. Psychol Bull 1993;113(3):553–65.
- Gracious BL, Finucane TL, Friedman-Campbell M, Messing S, Parkhurst MN. Vitamin D deficiency and psychotic features in mentally ill adolescents: a cross-sectional study. BMC Psychiatry 2012;12(1):1–9.
- Holick MF. The vitamin D epidemic and its health consequences. J Nutr 2005;135(11):2739S–48S.
- Misra M, Pacaud D, Petryk A, Collett-Solberg PF, Kappy M. Vitamin D deficiency in children and its management: review of current knowledge and recommendations. Pediatrics 2008;122(2):398–417.
- Patrick RP, Ames BN. Vitamin D and the omega-3 fatty acids control serotonin synthesis and action, part 2: relevance for ADHD, bipolar disorder, schizophrenia, and impulsive behavior. FASEB J 2015;29(6):2207–22.
- Jellen LC, Lu L, Wang X, Unger EL, Earley CJ, Allen RP, et al. Iron deficiency alters expression of dopamine-related genes in the ventral midbrain in mice. Neuroscience 2013;252:13–23.
- Del Campo N, Chamberlain SR, Sahakian BJ, Robbins TW. The roles of dopamine and noradrenaline in the pathophysiology and treatment of attention-deficit/hyperactivity disorder. Biol Psychiatry 2011;69(12):e145–57.
- Cortese S, Angriman M, Lecendreux M, Konofal E. Iron and attention deficit/hyperactivity disorder: what is the empirical evidence so far? A systematic review of the literature. Expert Rev Neurother 2012;12(10):1227–40.
- Zachor DA, Roberts AW, Hodgens JB, Isaacs JS, Merrick J. Effects of long-term psychostimulant medication on growth of children with ADHD. Res Dev Disa 2006;27(2):162–74.
- Heijtz RD, Wang S, Anuar F, Qian Y, Björkholm B, Samuelsson A, et al. Normal gut microbiota modulates brain development and behavior. Proc Natl Acad Sci USA 2011;108(7):3047–52.
- Ames BN. A role for supplements in optimizing health: the metabolic tune-up. Arch Biochem Biophys 2004;423(1):227–34.
- Cortese S, Panei P, Arcieri R, Germinario EA, Capuano A, Margari L, et al. Safety of methylphenidate and atomoxetine in children with attention-deficit/hyperactivity disorder (ADHD): data from the Italian national ADHD registry. CNS Drugs 2015;29(10):865–77.
- Petra AI, Panagiotidou S, Hatziagelaki E, Stewart JM, Conti P, Theoharides TC. Gut-microbiota-brain axis and its effect on neuropsychiatric disorders with suspected immune dysregulation. Clin Ther 2015;37(5):984–95.
- Jakobsson HE, Rodriguez-Pineiro AM, Schutte A, Ermund A, Boysen P, Bemark M, et al. The composition of the gut microbiota shapes the colon mucus barrier. EMBO Rep 2015;16(2):164–77.
- Ames BN, Elson-Schwab I, Silver EA. High-dose vitamin therapy stimulates variant enzymes with decreased coenzyme binding affinity (increased Km): relevance to genetic disease and polymorphisms. Am J Clin Nutr 2002;75(4):616–58.
- Krull KR, Brouwers P, Jain N, Zhang L, Bomgaars L, Dreyer Z, et al. Folate pathway genetic polymorphisms are related to attention disorders in childhood leukemia survivors. J Pediatr 2008;152(1):101–5.
- Saha T, Dutta S, Rajamma U, Sinha S, Mukhopadhyay K. A pilot study on the contribution of folate gene variants in the cognitive function of ADHD probands. Neurochem Res 2014;39(11):2058–67.
- Spellicy CJ, Northrup H, Fletcher JM, Cirino PT, Dennis M, Morrison AC, et al. Folate metabolism gene 5,10-methylenetetrahydrofolate reductase (MTHFR) is associated with ADHD in myelomeningocele patients. PloS One 2012;7(12):e51330.
- Castro R, Rivera I, Ravasco P, Camilo ME, Jakobs C, Blom HJ, et al. 5,10-methylenetetrahydrofolate reductase (MTHFR) 677C→T and 1298A→C mutations are associated with DNA hypomethylation. J Med Genet 2004;41(6):454–8.
- Rucklidge JJ, Johnstone J, Gorman B, Boggis A, Frampton CM. Moderators of treatment response in adults with ADHD treated with a vitamin–mineral supplement. Prog Neuropsychopharmacol Biol Psychiatry 2014;50:163–71.
- Javitt DC, Sershen H, Hashim A, Lajtha A. Inhibition of striatal dopamine release by glycine and glycyldodecylamide. Brain Res Bull 2000;52(3):213–6.
- Meinzer MC, Pettit JW, Waxmonsky JG, Gnagy E, Molina BS, Pelham WE. Does childhood attention-deficit/hyperactivity disorder (ADHD) predict levels of depressive symptoms during emerging adulthood? J Abnorm Child Psych 2016;44(4):787–97.
- Kotting WF, Bubenzer S, Helmbold K, Eisert A, Gaber TJ, Zepf FD. Effects of tryptophan depletion on reactive aggression and aggressive decision-making in young people with ADHD. Acta Psychiat Scand 2013;128(2):114–23.
- Zimmermann M, Grabemann M, Mette C, Abdel-Hamid M, Uekermann J, Kraemer M, et al. The effects of acute tryptophan depletion on reactive aggression in adults with attention-deficit/hyperactivity disorder (ADHD) and healthy controls. PloS One 2012;7(3):e32023.
- Arnold LE, Lofthouse N, Hurt E. Artificial food colors and attention-deficit/hyperactivity symptoms: conclusions to dye for. Neurotherapeutics 2012;9(3):599–609.